Abstract
SummaryThe antichymotrypsin content of serum, as found by this test, is not changed in early malignant disease. The presence of hidden metastatic cancer, however, can be detected. Thus the test may assist in the diagnosis of advanced malignancies or in detecting such lesions when they appear in an obscure state. False positive values with this procedure fall in the same group as with the methods which measure proteolysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
